Aurobindo Pharma Limited: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

Particulars	Sep-24	Dec-24	Mar-25	Jun-25	Sep-25	Dec-25	Mar-26	Jun-26
Revenue	7,796	7,979	8,382	7,868	8,286	8,646	8,853	9,150
Other income	136	157	135	105	121	188	117	264
Expenses	6,725	6,938	7,150	6,769	7,132	7,430	7,677	7,858
Cost of materials consumed	2,742	2,729	2,800	2,535	2,510	2,755	2,505	2,894
Purchases of stock-in-trade	747	824	636	808	846	893	931	932
Change in inventories	-279	-237	-8	-104	-17	-166	-8	-199
Employee benefit expense	1,109	1,132	1,163	1,229	1,277	1,310	1,374	1,480
Finance costs	113	118	115	98	95	93	98	102
Depreciation & amortisation	382	419	444	406	429	465	479	487
Other expenses	1,910	1,954	2,000	1,797	1,991	2,081	2,298	2,162
EBITDA	1,702	1,735	1,926	1,709	1,798	1,896	1,870	2,106
EBIT	1,320	1,316	1,482	1,303	1,369	1,431	1,391	1,619
Exceptional items	-	-	-	-	-	-65	-	-40
Profit Before Tax	1,207	1,198	1,367	1,205	1,274	1,338	1,293	1,517
Tax expense	391	354	432	383	428	429	370	483
Deferred tax	68	-144	2	-108	-35	45	-29	-127
Net Profit	817	846	903	824	848	910	921	1,032
Financial Ratios
Operating Profit Margin	16.93%	16.49%	17.68%	16.56%	16.52%	16.55%	15.71%	17.69%
EBITDA Margin	21.83%	21.74%	22.98%	21.72%	21.70%	21.93%	21.13%	23.02%
Net Profit Margin	10.48%	10.60%	10.77%	10.47%	10.23%	10.53%	10.40%	11.28%
Earnings Per Share (₹)	14.00	14.56	15.56	14.20	14.61	15.67	15.86	17.86

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.